(NMDA) is an acidic amino acid which depolarizes neurons by selectively interacting with a distinct class of excitatory amino acid receptor. Recent evidence has indicated that this receptor is a neurotransmitter receptor in the spinal cord, cerebral cortex, and hippocampus for which the endogenous ligand is likely to be L-glutamate or a structurally related compound.
Using quantitative autoradiography, we have studied the anatomical distribution of the class of L-[3H]glutamate-binding sites displaced by NMDA, which appear to correspond to NMDA receptors. The CA1 region of the hippocampus contains the highest density of sites. In general, telencephalic regions have high levels of binding sites. The cerebral cortex shows significant density variations among the differing layers and regions, with the highest levels found in the frontal cortex layers I to Ill. Within the basal ganglia, the highest levels are found in the nucleus accumbens, intermediate levels are found in the caudate/ putamen, and very low levels are found in the globus pallidus. Thalamic regions have moderate levels with variations among differing regions. Midbrain and brainstem have low levels of binding sites, but within these regions there are structures exhibiting higher levels, e.g., the nucleus of the solitary tract and the inferior olive. The distribution of NMDA sites is consistent with most, but not all, of the regions previously proposed to use glutamate as an excitatory transmitter. Thus, the distribution of NMDA-sensitive L-r3H]glutamate-binding sites suggests that the NMDA receptor represents a major, distinct subset of excitatory amino acid recep tors and indicates regions in which neurotransmission may be mediated or modulated by this receptor.
Evidence from a variety of experimental approaches suggests that the excitatory amino acid L-glutamate (and possibly related compounds) is a major neurotransmitter in the vertebrate CNS (Cotman et al., 1981; Watkins and Evans, 1981; Fagg and Foster, 1983; Fonnum, 1984) . Excitatory amino acid depolarizations appear to be mediated by at least three distinct receptor types which are characterized by selective interaction with N-methyl-o-aspartate (NMDA), quisqualate @A), and kainate (KA) (McLennan, 1981; Watkins and Evans, 1981; and Foster and Fagg, 1984) .
There is now compelling evidence that the receptor recognized by NMDA is involved in synaptic transmission. The dorsal rootevoked ventral root polysynaptic response in several vertebrate spinal cord preparations is antagonized by the appropriate spectrum of NMDA antagonists (Davies and Watkins, 1983) . The generation of long term potentiation in the Schaffer collateral pathway of the hippocampus is also antagonized by specific NMDA antagonists (Collingridge et al., 1983; Harris et al., 1984; Wigstrom and Gustafsson, 1984) . It has also been recently reported that, under certain conditions, EPSP and population spike responses within the hippocampus and cerebral cortex can be blocked by NMDA antagonists (Hablitz and Langmoen, 1984; Coan and Collingridge, 1985; Thomson et al., 1985) . Thus, although it remains for further electrophysiological investigation to specifically define the physiological role of NMDA receptors, it is well established that these receptors are involved in mediating some aspect of synaptic transmission. Thus, localization of the binding sites for NMDA also provides independent evidence for excitatory amino acid-mediated neurotransmission in the indicated regions. In addition, since it has been shown that seizure activity induced by a variety of agents (Croucher et al., 1982; Meldrum et al., 1983a, b) can be blocked by NMDA antagonists, the localization of NMDA sites may suggest regions where this potentially therapeutic action may occur.
In a previous report (Monaghan et al., 1983a) we have described a unique binding site for Q3H]glutamate which preferentially recognizes NMDA and exhibits the characteristic NMDA receptor pharmacology. We have also recently studied this binding site in membrane preparations (Yao et al., 1984) and found the pharmacological profile to be indicative of the NMDA receptor, as had been suggested by Fagg et al. (1983) . This binding site is enriched in synaptic plasma membranes and is further enriched in synaptic junctions. Fagg and Matus (1984) have recently reported that these sites are preferentially localized in isolated postsynaptic densities. The NMDA receptor identity of this binding site appears to be confirmed by the recent work of Olverman et al. (1984) (B,,) , and a similar distribution within the CNS. For both ligands, highest binding levels are found within the hippocampus, and they display identical distributions within this structure (Monaghan et al., 1983a (Monaghan et al., , 1984b .
The results of this study demonstrate that NMDA-binding sites exhibit a high degree of anatomical specificity. In general, their distribution agrees with the regions proposed to use glutamate for neurotransmission, suggesting that these sites represent a major subset of excitatory amino acid receptors. Preliminary results of this study have been presented in abstract form (Yao et al., 1984) .
Materials and Methods
Sprague-Dawley rats (150 to 300 gm) were decapitated, and the brains were rapidly removed and frozen on powdered dry ice. Tissue sections were 2909 prepared for autoradlography as previously described (Monaghan et al., 1983a (Simon et al., 1976; London and Coyle, 1979; Sharif and Roberts, 1981; Honore et al., 1982; Butcher et al., 1983; Fagg et al., 1983 , Monaghan et al., 1983a , b, 1984a . However, this concentration is high enough to displace greater than 90% of the binding to NMDA sites (Monaghan et al., 1983a; Fagg and Matus, 1984; Olverman et al., 1984 Paxinos and Watson (1982) . Cortical regions were compared to regions defined by Krieg (1946) . The radiolabel in the tissue at the end of the binding incubation appeared to be L-glutamate. #HIGlutamate bound to tissue sections and then extracted with 0.1 M acetic acid co-migrated with authentic glutamate on cellulose thin layer chromatography plates in an aqueous phenol solvent system.
In tissue sections used for kinetic and equilibrium bindlng measurements in whole tissue sections, the sections were treated as described above, but Instead of fully air-drying the tissue, the sections were wiped off the slide with Whatman GF/B glass fiber filters. The radioactivity in these sections was then determined by routine liquid scintillation spectrophotometry. Chemicals were obtained from Sigma Chemical Co. (St. Louis, MO) except unlabeled NMDA, which was obtained from Tocris Chemicals (Essex, United Kingdom).
Results

Binding characteristics L-[3H]
Glutamate bound to rat brain tissue sections in a saturable, reversible manner with a Kd of 0.48 f 0.07 pM and a B,, of 0.95 f 0.09 pmol/mg of protein ( Fig. 1) . Binding affinity determined within the stratum radiatum of the hippocampus using quantitative densitometry revealed an affinity of 0.24 _+ 0.06 PM and a B,, of 3.31 + 0.41 pmol/mg of protein, reflecting the higher levels of binding in this region. Equilibrium levels of binding were rapidly achieved ( Binding shows rapid association-and 'is readily reversible.
Zero rinse time, 100% binding levels for the dissociation rate experiment were determined by extrapolafion. Dissociation was effected by placing the slide into buffer (at arrow) wtthout the radioligand after the standard Incubation as described under "Materials and Methods." In B, the dissociation constant was determined by increasing concentrations of unlabeled L-glutamate.
The inset shows Scatchard analysis of equilibrium binding data (Scatchard, 1949) . Representative experiments are shown, and averaged results are presented under "Results."
that determined by equilibrium studies. When binding levels were determined at 7 set rinse time, higher than expected levels of binding were observed; this may partly be due to the lag time in changing the buffer composition surrounding the receptor within the tissue section, or to the presence of a rapidly dissociating component which could not be resolved. However, autoradiograms prepared with a short rinse time (5 set) exhibited a qualitatively similar distribution pattern, and the B,, value obtained in membrane preparations under conditions with no net dissociation (Yao et al., 1984) is similar to that obtained in this study.
In 50 mM Tris-acetate buffer and in the absence of Na', Ca'+, and Cl-ions, approximately 75% of the specifically bound L- [~H] glutamate binding was displaced by NMDA with an inhibition constant (K,) of 5.2 f 1.7 PM (n = 3, Fig. 2 ). Inhibition constant was determined from the relationship K,' = (1 + F/K,) where K,' = monly observed in layer Pa of the cortex. This was most readily observed in parietal cortex (Figs. 4 to 6) . Insular, entorhinal, and perirhinal cortices exhibit a uniform density through their layers. Among cortical regions, frontal, insular, pyriform, perirhinal, and anterior cingulate cortex display the highest levels, whereas temporal, occipital and parietal regions display intermediate levels (with slightly lower levels in the deep parietal cortex), and the posterior crngulate cortex displays the lowest levels (cf. Figs. 5 and 6). In parasagittal sections near the midline, a distinct border was observed between anterior and posterior cingulate cortex. Likewise, an abrupt change in receptor density is observed in horizontal sections at the perirhinal-entorhinal border (Fig. 4) .
NMDA-sensitive L-[3H]glutamate-binding sites are particularly enriched in regions relating to olfaction. Within the olfactory bulb itself, there is a distinct lamination with higher binding levels in the external plexiform layer (Fig. 5A) . In addition to high levels in primary olfactory Within the basal ganglia and basal forebrain, the caudate/putamen and especially the nucleus accumbens exhibit high levels of binding (Fig. 5, D and E) . The globus pallidus, ventral palladium, and -slope-' from the plot of percentage inhibition versus percentage substantia innominata have a low density of binding sites with slightly inhibition/concentration of inhibitor, and F and K, represent, respechigher levels in the latter two regions (Fig. 5E , Table I ). The bed tively, the free concentration and the dissociation constant of L-[~H] nucleus of the stria terminalis and medial septum have moderate to glutamate. It is unlikely that the binding represents uptake because: low densities, whereas the lateral septum has higher levels of binding (1) Na+ and Cl-ions were absent from the incubation buffer (these (Fig. 5, D and E). The nucleus of the lateral olfactory tract has ions have been reported to be necessary for Na+-dependent uptake moderately high levels (Fig. 6A) . In the amygdala, the amygdala- (Bennett et al., 1972) and Cl--dependent uptake (Waniewski and hippocampal transition region and posterior cortical amygdala have Martin, 1983 Martin, , 1984 ); (2) binding was not decreased by incubating high levels of binding, as do the lateral and especially the basolateral at 0°C; (3) binding is enriched in membrane-solubilized synaptic amygdaloid nuclei. In contrast, the anterior cortical, central, and junctions (Yao et al., 1984) and postsynaptic densities (Fagg and medial amygdala regions have relatively low concentrations (Fig. 6 , Matus, 1984); and (4) the pharmacological profile does not corre-A and 13). spond to glutamate uptake systems (Balcar and Johnston, 1972;  As previously reported (Monaghan et al., 1983a) , the hippocampal Waniewski and Martin, 1984). As previously discussed, the binding formation has a distinctive distribution of NMDA sites. Highest levels site pharmacology corresponds to that expected for the NMDA are found in the stratum oriens and stratum radiatum of area CA1 , receptor (Monaghan et al., 1983a) and also corresponds to that and in the inner molecular layer of the dentate gyrus. Moderately determined by using D-[~H]AP~ to label NMDA receptors (Olverman high levels are found in CA3 stratum oriens and stratum radiatum, et al., 1984) .
CA1 stratum lacunosum-moleculare, and the dentate gyrus outer Distribution of NMDA-sensitive binding sites. The values listed in (outer two-thirds) molecular layer. Low levels are found over the cell Table I represent levels of binding which are displaced by 100 ELM body layers, the hilar region, and the stratum lucidum of CA3 (Fig. NMDA determined in various brain regions by quantitative autora-6, B and C). diography. As shown in Figure 3 , with the conditions used in these
In general, the thalamus has moderate levels of binding whereas experiments, essentially all regions of the brain show a predominately the hypothalamus has low levels. Within the thalamus the anterior NMDA-sensitive binding site. The most notable exception is the dorsal, lateral dorsal, lateral posterior, and midline nuclei (i.e., rhomstratum lucidum of the hippocampus (Fig. 3B) , where the mossy boid, reuniens, mediodorsal, intermediodorsal, and central medial fiber terminal zone is located. This layer contains a predominately thalamic nuclei) have slightly higher levels than the ventroposterior KA-sensitive population of Q3H]glutamate-binding sites (Monaghan and ventrolateral nuclei. The thalamic reticular nucleus and zona et al., 1983a). NMDA-insensitive binding under the conditions used incerta have approximately half the binding of the former thalamic in this study represent primarily KA-sensitive binding sites and the regions (Fig. 6, A (Fig. 4) . Telencephalic structures have high levels of binding. Cere-of higher levels in the central gray (especially the dorsal portion), the bral cortex, hippocampus, and striatum account for much of the superficial gray layer of the superior colliculus, the interpeduncular NMDA site binding, whereas midbrain and brainstem have low levels. nucleus, and the cuneiform nucleus. The inferior colliculus exhibits Overall, binding is higher in dendritic zones than in white matter a gradient in NMDA site density with higher levels in the dorsal regions. After taking into account the lower tritium efficiency over medial region and lower levels in the ventral lateral region (Fig. 7 , B white matter (Alexander et al., 1981) there is still a marked preferand C). This gradient roughly parallels that seen for glutamate levels ence for dendritic zones. Cell body layers generally have low levels (Adams and Wenthold, 1979) . As shown in Figure 7 , the brain stem of binding, with the exception of the granule cell layer of the shows little binding, but higher levels were found in the parabrachial cerebellum.
nucleus, the nucleus of the solitary tract, the inferior olivary complex, Cerebral cortex exhibits both regional and laminar variations in the hypoglossal nucleus, the medial vestibular nucleus and the NMDA site density. These variations are demonstrated in Figure 4 . granule cell layer of the dorsal cochlear nucleus. Within the parabraIn neocortex the outer layers I to Ill have a greater density than the chial nucleus, a small region in the lateral portion, which corresponds deeper layers. In addition, a slightly higher density band was com-to the Kolliker-Fuse nucleus (Paxinos and Watson, 1982) shows clearly higher levels of binding (Fig. 7C) . The cerebellum has higher levels of binding in the granule cell layer than in the molecular layer and deep nuclei (Fig. 7, D to F) . The spinal cord is low in these binding sites with the exception of the substantia gelatinosa of the dorsal horn (Fig. 7F) In the text. In 13, radroligand was incubated in the presence of 100 PM NMDA, which inhibited the brndrng In nearly all brain regions with the major exception of the hippocampal stratum lucidurn, termination zone of the mossy fiber system (Mf).
campus, cortex, solitary tract nucleus, and dorsal horn of spinal cord. Other recent reports have provided further correspondence between glutamate-using pathways and regions with a high density of NMDA sites, for example, the nucleus of the lateral olfactory tract (Fuller et al., 1984) and the dorsal cochlear nucleus (Potashner, 1983) . Most regions proposed to use NMDA receptors in synaptic transmission exhibit relatively high levels of NMDA site binding. On the basis of pharmacological characterization, it has been proposed that the stratum radiatum of hippocampus (Collingridge et al., 1983; Harris et al., 1984; Wigstrom and Gustafsson, 1984; Hablitz and Langmoen, 1984; Coan and Collingridge, 1985) intracortical pathways (Hicks and Geddes, 1981) and olfactory cortex (Collins, 1982) use NMDA receptors for synaptic transmission. These regions contain significant levels of binding sites for NMDA. Using ion-sensitive electrodes, Pumain and Heinemann (1981) and Pumain et al. (1984) found that L-glutamate and NMDA excitation in the rat cerebral cortex exhibited a laminar distribution parallel to the distribution of NMDA sites within the cortex; greater L-glutamate and NMDA response was found in the superficial cortical layers. Luini et al. (1981) reported that NMDA was the most potent agonist tested in eliciting Na+ fluxes in striatal slices. Also consistent with the NMDA receptor drstributron described here are the observations of Perkins and Stone (1983) who found that the NMDA agonist quinolinate and by: red-yellow-green-blue. The autoradiogram was prepared as previously described (Monaghan et al., 1983a) . With color enhancement, variations within the cerebral cortex become readily apparent; note the relatively low levels of binding in the parietal cortex and the lack of lamination within the entorhinal cortex. E, entorhinal cortex; f, frontal cortex; f', perirhinal cortex; PA, parietal cortex; 7, temporal cortex.
NMDA exhibit higher potencies in cortex, hippocampus, and striatum Given the tentative correspondence between NMDA-binding sites than in lower brain structures. It is difficult to compare the autoradiand regions which use NMDA receptors, one would predict that the ographically determined distribution of NMDA sites to various other regions described above which have a high density of NMDA sites studies of the blockade of synaptic responses by iontophoretically are likely to use this receptor in excitatory amino acid neurotransapplied NMDA antagonists because the antagonist concentration mission. Although it is often difficult to associate a specific pathway and, hence, the specificity are uncertain. Furthermore, extracellularly with a region of high NMDA site density, it is worth noting that some recorded EPSP response inhibition by NMDA antagonists may not regions which exhibit variations in NMDA site density also exhibit reveal NMDA receptor activity (Collingridge et al., 1983 ; Hablitz and similar variations in their cortical afferents. For example, regions of Langmoen, 1984; Harris et al., 1984; Wigstrom and Gustafsson, high binding site density within the amygdala and the cingulate 1984; Coan and Collingridge, 1985) . Thus, the distribution of NMDA cortex receive cortical inputs different from those in the respective sites described here is consistent with that expected for NMDA low density regions (Vogt et al., 1981; Ottersen, 1982 clamp experiments indicate that NMDA receptors activate a channel which exhibits voltage-dependent behavior in the presence of Mg*+ (Flatman et al., 1983; Mayer et al., 1984; Nowak et al., 1984) . Within the region of highest binding site density, the stratum radiatum of CA1 hippocampus, NMDA receptor blockade blocks the formation of long-term potentiation without blocking the extracellularly recorded EPSP. Together these results indicate that NMDA receptor function may be more complex than the generation of fast EPSPs.
A modulatory function could also explain why NMDA-binding sites exhibit a largely overlapping distribution with the other excitatory amino acid receptors, QA, as labeled by [3H]AMPA (Monaghan et al., 1984a; Rainbow et al., 1984) and KA, as labeled by [3H]KA (Monaghan and Cotman, 1982; Unnerstall and Wamsley, 1983) . Thus, one region may have two receptors for the same transmitter. In CA1 hippocampus, most evidence favors a KA/QA receptor for mediation of the Schaffer collateral EPSP (Koerner and Cotman,
